# Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT

> **NCT00725946** · EARLY_PHASE1 · TERMINATED · sponsor: **Stanford University** · enrollment: 7 (actual)

## Conditions studied

- Breast Cancer
- Breast Cancer Early Stage Breast Cancer (Stage 1-3)
- Breast Cancer Metastatic Breast Cancer

## Interventions

- **DRUG:** Iodine-124
- **RADIATION:** PET/CT with Iodine-124

## Key facts

- **NCT ID:** NCT00725946
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2017-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00725946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00725946, "Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00725946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*